APP and Alzheimer disease: Transgenic mice that overexpress mutated APP and Aβ-producing enzymes demonstrate many AD-like features, including Aβ deposition in the hippocampal and cortical areas, neurodegeneration, neuroinflammation, phospholipid changes, and memory loss [6,7].